Hydrogen Gas Protects Heart from Sepsis-Related Damage in Mice
H2 Protects Against Lipopolysaccharide-Induced Cardiac Dysfunction via Blocking TLR4-Mediated Cytokines Expression
Research hubs: Cardiovascular System
This research was done in animals. Results in animals often don't carry over to people.
- Evidence type
- Animal study (mouse)
- Authors
- Sihua Tan, Zhiyuan Long, Xiangping Hou, Yujie Lin, Jingting Xu, Xinchao You, Tinghuai Wang, Yaxing Zhang
- Journal
- Frontiers in Pharmacology
- Year
- 2019
- PMID
- 31440160
- Study Type
- Mouse
- Delivery
- Gas
- Dose
- Intraperitoneal injection for 4 days; hydrogen-rich medium for 30 min in vitro
- Duration
- 4 days
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 30 (OpenAlex, as of November 2026)
- Country
- China
TL;DR
Hydrogen gas treatment can improve heart function and reduce inflammation in mice with heart damage caused by sepsis.
Key Finding
Hydrogen gas protected heart function in mice exposed to bacterial toxin by suppressing inflammatory pathways and reducing pro-inflammatory chemicals like TNFα, IL-1β, and IL-18.
Summary
Researchers tested whether hydrogen gas could protect the heart from damage caused by lipopolysaccharide (LPS), a bacterial toxin that triggers sepsis (a life-threatening infection response). In mice and heart cells, hydrogen gas reduced the inflammatory response and improved heart function after LPS exposure by blocking a specific immune pathway called TLR4 and reducing harmful inflammatory chemicals.
Practical Takeaway
This is early research in mice and cell cultures only, not humans. While the results suggest hydrogen may have anti-inflammatory effects on the heart during severe infection, much more research—including human studies—would be needed before any therapeutic claims could be made. This work is preliminary and addresses a specific medical condition (septic cardiomyopathy) rather than general health.
Abstract (excerpt)
Background and Purpose: Septic cardiomyopathy, which is one of the features of multi-organ dysfunction in sepsis, is characterized by ventricular dilatation, reduced ventricular contractility, and reduction in ejection fraction and, if severe, can lead to death. To date, there is no specific…